Tuberculosis (TB): Blood Test

Hospitals and community-based residential facilities (CBRFs) are the only two providers in Wisconsin for which the TB skin test is specified in the requirements. For all other types of licensed providers that require screening for infectious diseases (nursing homes, facilities for the developmentally disabled, etc.), the TB skin test is not specified. Thus, all other providers may also choose to screen for tuberculosis infection using QFT-G in place of the TB skin test without any special variance or waiver.

Interferon-Gamma Release Assays (IGRAs) - Blood Tests for TB Infection

QuantiFERON®-TB Gold test (QFT-G), a whole-blood test for use in detecting Mycobacterium tuberculosis infection, received U.S. Food and Drug Administration (FDA) approval in 2005.

QFT-G may be used in ALL occupational settings in place of a skin test.

The Tuberculosis Program can provide additional information about the use of QuantiFERON®-TB Gold in Wisconsin.

Facilities in/near Wisconsin offering QuantiFERON®-TB Gold 

Facilities listed are provided for convenience purposes only. Their use does not imply endorsement by the Wisconsin Department of Health Services. Call the individual facility for details.

  • ACL Laboratories (PDF)
    Multiple locations

  • Beloit Clinic
    Beloit, Wisconsin

  • Consultants Laboratory
    Fond du Lac, Wisconsin

  • Dynacare Laboratories
    Milwaukee, Wisconsin

  • Meriter Hospital
    Madison, Wisconsin

  • SMDC Clinical Laboratory
    Duluth, Minnesota

  • St. Elizabeth Hospital Laboratory
    Appleton, Wisconsin

  • St. Vincent Hospital
    Green Bay, Wisconsin

  • West Bend Clinic
    West Bend, Wisconsin
    262-334-3451, ext. 2304
    262-334-3451, ext. 2365

For more information or questions, contact the Respiratory Diseases and International Health Unit or your Wisconsin Local Health Department.

Last Revised: September 28, 2018